Sterling Capital Management LLC decreased its position in K2M Group Holdings, Inc. (NASDAQ:KTWO) by 2.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 102,507 shares of the medical device company’s stock after selling 2,971 shares during the quarter. Sterling Capital Management LLC owned about 0.24% of K2M Group Holdings worth $2,497,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of KTWO. California State Teachers Retirement System grew its position in K2M Group Holdings by 41.8% during the second quarter. California State Teachers Retirement System now owns 71,871 shares of the medical device company’s stock worth $1,751,000 after buying an additional 21,200 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in K2M Group Holdings by 51.0% during the second quarter. The Manufacturers Life Insurance Company now owns 31,807 shares of the medical device company’s stock worth $774,000 after buying an additional 10,738 shares in the last quarter. State Street Corp grew its position in K2M Group Holdings by 39.8% during the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock worth $17,378,000 after buying an additional 203,067 shares in the last quarter. Macquarie Group Ltd. grew its position in K2M Group Holdings by 0.3% during the second quarter. Macquarie Group Ltd. now owns 200,656 shares of the medical device company’s stock worth $4,888,000 after buying an additional 581 shares in the last quarter. Finally, Broadview Advisors LLC grew its position in K2M Group Holdings by 10.2% during the second quarter. Broadview Advisors LLC now owns 379,300 shares of the medical device company’s stock worth $9,240,000 after buying an additional 35,150 shares in the last quarter. 97.77% of the stock is currently owned by institutional investors.

K2M Group Holdings, Inc. (NASDAQ:KTWO) traded up 1.44% during midday trading on Tuesday, reaching $19.70. The company’s stock had a trading volume of 49,380 shares. The stock has a 50-day moving average price of $21.53 and a 200 day moving average price of $22.50. K2M Group Holdings, Inc. has a 12 month low of $16.32 and a 12 month high of $25.99. The company’s market cap is $852.38 million.

K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.01. The firm had revenue of $65.70 million during the quarter, compared to analyst estimates of $66.26 million. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.27) EPS. Analysts expect that K2M Group Holdings, Inc. will post ($0.82) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/sterling-capital-management-llc-decreases-stake-in-k2m-group-holdings-inc-ktwo/1636642.html.

In other news, insider John Philip Md Kostuik sold 1,332 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $23.30, for a total transaction of $31,035.60. Following the completion of the transaction, the insider now directly owns 200,629 shares in the company, valued at approximately $4,674,655.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 2,350 shares of the business’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $56,588.00. Following the transaction, the chief financial officer now owns 55,158 shares of the company’s stock, valued at $1,328,204.64. The disclosure for this sale can be found here. Insiders have sold a total of 44,129 shares of company stock valued at $1,033,644 over the last 90 days. Company insiders own 5.80% of the company’s stock.

KTWO has been the topic of a number of analyst reports. Cowen and Company reissued a “buy” rating and set a $26.00 price target on shares of K2M Group Holdings in a research report on Wednesday, July 19th. Oppenheimer Holdings, Inc. reissued a “buy” rating on shares of K2M Group Holdings in a research report on Thursday, June 22nd. JMP Securities reissued an “outperform” rating and set a $30.00 price target (up previously from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. Royal Bank Of Canada reissued a “buy” rating and set a $26.00 price target on shares of K2M Group Holdings in a research report on Friday, September 22nd. Finally, Needham & Company LLC reissued a “strong-buy” rating and set a $27.00 price target (down previously from $29.00) on shares of K2M Group Holdings in a research report on Monday, October 9th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. K2M Group Holdings presently has a consensus rating of “Buy” and an average price target of $25.60.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Institutional Ownership by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.